YiChang HEC ChangJiang Pharmaceutical Co Ltd 2020 SR

The report highlights the company's performance in 2020, focusing on its response to the COVID-19 pandemic and its commitment to carbon neutrality. Key achievements include the approval of several new drugs, such as Emitasvir Phosphate Capsules and Recombinant Human Insulin Injection, expanding its portfolio in anti-viral and endocrine treatments. The company established an internal ESG monitoring mechanism and emphasized green production, achieving 100% compliance in pollutant emissions. Socially, it focused on employee safety, anti-corruption, and community support, including a RMB 1 million donation to the Wuhan Charity Federation.

Company: YiChang HEC ChangJiang Pharmaceutical Co Ltd

Sector: Health Care

Country: China

Year: 2020

Type: SR

Pages: 96

Back to company

YiChang HEC ChangJiang Pharmaceutical Co Ltd

YiChang HEC ChangJiang Pharmaceutical Co Ltd 2020 ESG Report

ESG Report

The report highlights the company's performance in 2020, focusing on its response to the COVID-19 pandemic and its commitment to carbon neutrality. Key achievements include the approval of several new drugs, such as Emitasvir Phosphate Capsules and Recombinant Human Insulin Injection, expanding its portfolio in anti-viral and endocrine treatments. The company established an internal ESG monitoring mechanism and emphasized green production, achieving 100% compliance in pollutant emissions. Socially, it focused on employee safety, anti-corruption, and community support, including a RMB 1 million donation to the Wuhan Charity Federation.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2020

Reporting Period

Jan 1, 2020 - Dec 31, 2020

Fiscal Year

2020

Published

Mar 19, 2021

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Materiality Assessment

Sustainable Development Goals

Other Standards

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Water Consumption

Total Waste

Workplace Fatalities

Employees